Filtros de búsqueda

Lista de obras de

17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy

artículo científico publicado en 2011

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.

artículo científico publicado en 2016

A Case Report of Breast Cancer with Extensive Pulmonary Lymphovascular Tumor Emboli ⬇️

artículo científico publicado el 28 de marzo de 2012

A Case of Disseminated Skin and Soft Tissue Infection due toMycobacterium abscessuswith Metastatic Breast Cancer

scholarly article by Ji Eun Kwon et al published 2012 in Infection & chemotherapy

A Case of Primary Gastric Choriocarcinoma Presenting with Amenorrhea

artículo científico

A Clinical Analysis of PTEN Expressions in Breast Cancers

artículo científico publicado en 2003

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer

artículo científico publicado en 2016

A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions

artículo científico publicado en 2014

A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer

artículo científico publicado en 2014

A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker

artículo científico publicado el 1 de mayo de 2008

A Possible Association Between Thyroid Cancer and Breast Cancer

artículo científico publicado en 2015

A case of desmoplastic small round cell tumor diagnosed in a young female patient

artículo científico publicado en 2009

A case of pyothorax-associated lymphoma simulating empyema necessitatis ⬇️

artículo científico publicado el 1 de mayo de 2003

A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma

artículo científico publicado en 2004

A first in human study of the new oral selective estrogen receptor degrader AZD9496 for HR+/HER2- advanced breast cancer.

artículo científico publicado en 2018

A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes

artículo científico publicado en 2014

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

artículo científico publicado en 2004

A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer

artículo científico publicado en 2015

A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group

artículo científico publicado en 2014

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2018

A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial

artículo científico publicado en 2018

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.

artículo científico publicado en 2018

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09

artículo científico publicado en 2015

A-kinase anchoring protein 12 regulates the completion of cytokinesis

artículo científico publicado en 2008

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

artículo científico publicado en 2014

ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy

artículo científico publicado en 2012

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

artículo científico publicado en 2017

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial

scientific article published on 27 April 2020

Abstract 3815: Overcoming acquired resistance of Lapatinib in breast cancer with Palbociclib

scholarly article

Abstract 4914: Pregnancy and breast cancer outcomes

scholarly article

Abstract CT141: Genetic landscape of premenopausal HR+/HER2- advanced breast cancer (ABC) based on comprehensive circulating tumor DNA analysis and association with clinical outcomes in the Phase III MONALEESA-7 trial

scholarly article

Abstract P2-13-07: Zanidatamab (ZW25), a HER2-targeted bispecific antibody, in combination with chemotherapy (chemo) for HER2-positive breast cancer (BC): Results from a phase 1 study

artículo científico publicado en 2022

Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features

artículo científico publicado en 2016

Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial

scientific article published on 16 September 2019

Adenoid cystic carcinoma of the breast: a case series of six patients and literature review

scientific article published on 15 January 2014

Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion.

artículo científico publicado en 2003

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

artículo científico publicado en 2017

Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer

artículo científico publicado en 2020

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

artículo científico publicado en 2013

Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience

artículo científico publicado en 2012

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study

artículo científico publicado en 2009

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer

artículo científico publicado en 2016

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial

artículo científico publicado en 2016

Age <40Years is an independent prognostic factor predicting inferior overall survival in patients treated with breast conservative therapy

artículo científico publicado en 2010

Aggressiveness of cancer-care near the end-of-life in Korea

artículo científico publicado en 2008

Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy

artículo científico publicado en 2019

Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer

artículo científico publicado en 2015

An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients

artículo científico publicado en 2014

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer ⬇️

artículo científico publicado el 22 de febrero de 2011

Androgen receptor inhibitor enhances the anti-tumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response

scientific article published on 19 September 2018

Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells

artículo científico publicado en 2016

Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis

artículo científico publicado en 2016

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells ⬇️

artículo científico publicado el 1 de marzo de 2012

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer ⬇️

artículo científico publicado el 28 de marzo de 2011

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

artículo científico publicado en 2011

Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells

artículo científico publicado en 2006

Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer ⬇️

artículo científico publicado el 9 de noviembre de 2012

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer

artículo científico

Artificial nutrition and hydration in terminal cancer patients: the real and the ideal

scientific article published on 11 November 2006

Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer

artículo científico

Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients

artículo científico publicado en 2020

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.

artículo científico publicado en 2011

Ataxia‐telangiectasia‐mutated protein expression with microsatellite instability in gastric cancer as prognostic marker ⬇️

artículo científico publicado el 17 de septiembre de 2013

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model

artículo científico publicado en 2010

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

artículo científico publicado en 2012

Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation

artículo científico publicado en 2016

Bilateral Salpingo-Oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors

artículo científico publicado en 2017

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

artículo científico publicado en 2010

Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer

scientific article published on 16 September 2019

Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.

artículo científico publicado en 2014

Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data ⬇️

artículo científico publicado el 31 de diciembre de 2012

Breast Cancer Molecular Phenotype and the Use of HER2-Targeted Agents Influence the Accuracy of Breast MRI After Neoadjuvant Chemotherapy ⬇️

artículo científico publicado el 1 de enero de 2013

Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging

artículo científico publicado en 2014

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

artículo científico publicado en 2012

Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients ⬇️

artículo científico publicado el 16 de marzo de 2013

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

artículo científico publicado en 2018

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

artículo científico publicado en 2017

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

artículo científico publicado en 2017

CD24 expression predicts distant metastasis in extrahepatic bile duct cancer

artículo científico publicado en 2013

CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience

artículo científico publicado en 2005

Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study ⬇️

artículo científico publicado el 14 de abril de 2011

Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea

artículo científico publicado en 2019

Challenging problems in advanced malignancy: Case 1. Chylopericardium during the treatment of non-Hodgkin's lymphoma

artículo científico publicado en 2003

Change in topoisomerase 1 (Top1) positive circulating tumor cells impacts overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol

artículo científico publicado en 2018

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

artículo científico publicado en 2011

Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery

article

Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer

artículo científico publicado en 2009

Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial

scientific article published on 06 August 2018

Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients

scientific article published on 07 May 2020

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer

artículo científico publicado en 2015

Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors

artículo científico publicado en 2008

Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung Cancer

artículo científico publicado en 2013

Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit

artículo científico publicado en 2016

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma

artículo científico publicado en 2015

Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung)

scientific article published on 01 December 2012

Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib

artículo científico publicado en 2020

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

artículo científico publicado en 2011

Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy

artículo científico publicado en 2011

Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients

artículo científico publicado en 2006

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.

artículo científico

Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer

artículo científico

Clinicopathologic Characteristics of Patients With Stage III/IV (M0) Advanced Gastric Cancer, According to HER2 Status Assessed by Immunohistochemistry and Fluorescence In Situ Hybridization ⬇️

artículo científico publicado el 1 de junio de 2011

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer ⬇️

artículo científico publicado el 19 de mayo de 2011

Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective study

artículo científico publicado en 2010

Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant

artículo científico publicado en 2020

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

artículo científico publicado en 2016

Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.

artículo científico publicado en 2010

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

artículo científico publicado en 2009

Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.

artículo científico publicado en 2014

Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells

artículo científico publicado en 2008

Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer

artículo científico publicado en 2020

Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer

artículo científico

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

scientific article published on 16 October 2015

Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II – III invasive breast cancer: the OOTR-N001 study ⬇️

artículo científico publicado el 1 de marzo de 2013

Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer

artículo científico publicado en 2011

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

scientific article published on 01 December 2019

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

artículo científico publicado en 2012

Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer ⬇️

artículo científico publicado el 27 de julio de 2012

Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

artículo científico publicado en 2016

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.

artículo científico

Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).

artículo científico publicado en 2008

Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells

artículo científico publicado en 2018

Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis

artículo científico publicado en 2017

Cytotoxic effects of pemetrexed in gastric cancer cells

artículo científico publicado en 2005

DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells

artículo científico publicado en 2010

DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription

artículo científico publicado en 2008

DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1.

artículo científico publicado en 2008

Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin

artículo científico publicado en 2002

Design and efficacy of a monovalent bispecific PD-1/CTLA-4 antibody that enhances CTLA-4 blockade on PD-1+ activated T cells

artículo científico publicado en 2021

Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast Cancer

scientific article published on 21 August 2019

Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection

artículo científico publicado en 2011

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX.

artículo científico publicado en 2015

Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer ⬇️

artículo científico publicado el 30 de abril de 2013

Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab ⬇️

artículo científico publicado el 15 de marzo de 2011

Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression?

artículo científico publicado en 2007

Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer

artículo científico publicado en 2012

Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype

artículo científico

Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.

artículo científico publicado en 2005

Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy?

artículo científico publicado en 2008

Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer ⬇️

artículo científico publicado el 1 de julio de 2011

Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells

artículo científico publicado en 2011

EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release

artículo científico publicado en 2017

ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis

artículo científico publicado en 2011

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

artículo científico publicado en 2007

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy ⬇️

artículo científico publicado el 20 de octubre de 2011

Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel (1)H-magnetic resonance spectroscopy and (18)F-fluorodeoxyglucose positron emission tomography.

artículo científico

Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane

artículo científico publicado en 2015

Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer

artículo científico publicado en 2020

Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy

artículo científico publicado en 2018

Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program

artículo científico publicado en 2016

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

artículo científico publicado en 2012

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea

artículo científico publicado en 2016

Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitors

artículo científico publicado en 2013

Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting

artículo científico publicado en 2011

Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells

artículo científico publicado en 2008

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer

artículo científico publicado en 2005

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.

artículo científico publicado en 2008

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.

artículo científico publicado en 2009

Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer

artículo científico

Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma

artículo científico publicado en 2008

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.

artículo científico publicado en 2017

Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines

artículo científico publicado en 2013

Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expression

artículo científico

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.

artículo científico publicado en 2015

Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer ⬇️

artículo científico publicado el 1 de diciembre de 2011

Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer

artículo científico publicado en 2022

Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)

scientific article published on 12 August 2019

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response

artículo científico publicado en 2013

Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer

artículo científico

Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer

artículo científico publicado en 2016

Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer

artículo científico publicado en 2010

Expression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factors

artículo científico publicado en 2005

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer

artículo científico publicado en 2016

Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results

artículo científico publicado en 2016

First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer

artículo científico publicado en 2004

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma

artículo científico publicado en 2006

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study

artículo científico publicado en 2020

Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-l

artículo científico publicado en 2018

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind

artículo científico publicado en 2016

Gefitinib trial in a fanconi's anemia patient with multiple squamous cell carcinomas and hepatocellular carcinoma.

artículo científico publicado en 2005

Gemcitabine and Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Clinical Benefit Response-Oriented Phase II Study

artículo científico publicado en 2003

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

artículo científico publicado en 2008

Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer

scientific article published on 30 June 2008

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

artículo científico publicado en 2008

Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers

artículo científico publicado en 2012

Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy

artículo científico publicado en 2013

HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer

artículo científico publicado en 2014

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer ⬇️

artículo científico publicado el 15 de mayo de 2013

HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor

artículo científico publicado en 2020

Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial ⬇️

artículo científico publicado en 2017

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies

scientific article published on 12 March 2020

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody ⬇️

artículo científico publicado el 16 de marzo de 2012

High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy

artículo científico publicado en 2006

High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer ⬇️

artículo científico publicado el 9 de octubre de 2010

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization

artículo científico publicado en 2005

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

artículo científico publicado en 2015

Homologous repair deficiency score for identifying breast cancers with defective DNA damage response

artículo científico publicado en 2020

Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics

artículo científico publicado en 2017

Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study ⬇️

artículo científico publicado el 7 de diciembre de 2011

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patients

scientific article published on 11 July 2019

Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor

scientific article published on 04 November 2019

Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer

artículo científico publicado en 2014

Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer

artículo científico

Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors

artículo científico publicado en 2014

Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)

artículo científico publicado en 2020

Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.

artículo científico publicado en 2017

Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study ⬇️

artículo científico publicado el 24 de noviembre de 2010

Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer

artículo científico publicado en 2010

Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy

artículo científico publicado en 2017

Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study

artículo científico publicado en 2012

Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer

artículo científico publicado en 2007

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2017

Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer

artículo científico publicado en 2008

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival ⬇️

artículo científico publicado el 25 de diciembre de 2012

Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?

artículo científico publicado en 2015

Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?

artículo científico publicado en 2009

KRAS Mutation Status and Clinical Outcome of Preoperative Chemoradiation With Cetuximab in Locally Advanced Rectal Cancer: A Pooled Analysis of 2 Phase II Trials ⬇️

artículo científico publicado el 5 de junio de 2012

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach

artículo científico publicado en 2010

KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.

artículo científico publicado en 2014

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis ⬇️

artículo científico publicado el 2 de marzo de 2011

Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer

artículo científico

Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate

artículo científico publicado en 2017

Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy

artículo científico publicado en 2012

Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.

artículo científico publicado en 2018

Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2.

artículo científico publicado en 2009

Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer

artículo científico publicado en 2017

Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer ⬇️

artículo científico publicado el 28 de junio de 2013

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type

artículo científico publicado en 2005

Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

artículo científico publicado en 2016

Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer

artículo científico

Low adherence to upfront and extended adjuvant letrozole therapy among early breast cancer patients in a clinical practice setting

artículo científico publicado en 2014

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

artículo científico publicado en 2019

Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients ⬇️

artículo científico publicado el 5 de febrero de 2011

Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications

artículo científico publicado en 2015

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications

artículo científico publicado en 2015

Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity

artículo científico publicado en 2009

Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer

artículo científico publicado en 2008

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

artículo científico publicado en 2012

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

artículo científico publicado en 2008

Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-

artículo científico publicado en 2019

More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity

artículo científico publicado en 2016

Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer

scientific article published on 01 July 2019

Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment

artículo científico publicado en 2008

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

artículo científico publicado en 2007

Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study

artículo científico publicado en 2015

NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations ⬇️

artículo científico publicado el 8 de diciembre de 2011

Neoadjuvant chemotherapy followed by limited surgery in a mouse model of head and neck cancer.

artículo científico publicado en 2009

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer

artículo científico publicado en 2016

New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12)

scientific article published on 04 January 2021

New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer

artículo científico

Nomogram for predicting breast conservation after neoadjuvant chemotherapy

artículo científico publicado en 2014

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

artículo científico publicado en 2011

Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.

artículo científico publicado en 2013

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells ⬇️

artículo científico publicado el 10 de febrero de 2013

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

scientific article published on 06 August 2020

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

artículo científico publicado en 2017

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2017

Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis

artículo científico publicado en 2020

Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer

artículo científico publicado en 2015

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy

scientific article published on 19 April 2018

Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients

artículo científico publicado en 2004

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

artículo científico publicado en 2015

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles

artículo científico publicado en 2016

Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation

artículo científico publicado en 2006

Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy

artículo científico publicado en 2016

Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer ⬇️

artículo científico publicado el 29 de junio de 2012

Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases

artículo científico publicado en 2012

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

artículo científico publicado en 2019

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

artículo científico publicado en 2019

Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells

artículo científico publicado en 2008

Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer

artículo científico

PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocr

artículo científico publicado en 2017

PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation

scientific article published on 08 February 2020

Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results

artículo científico publicado en 2017

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study

artículo científico publicado en 2019

Palbociclib and Letrozole in Advanced Breast Cancer

artículo científico publicado en 2016

Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies

artículo científico publicado en 2018

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2

scientific article published on 24 October 2019

Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

artículo científico publicado en 2008

Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells.

artículo científico publicado en 2018

Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)

artículo científico publicado en 2020

Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial

scientific article published on 22 August 2019

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

scientific article published on 01 December 2020

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

artículo científico publicado en 2012

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

scientific article published on 12 March 2020

Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer ⬇️

artículo científico publicado el 13 de enero de 2013

Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

scientific article published on 01 September 2019

Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

artículo científico publicado en 2017

Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer

artículo científico publicado en 2015

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer

artículo científico publicado en 2012

Phase II study of Avelumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib

artículo científico publicado en 2020

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

artículo científico publicado en 2010

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer

artículo científico publicado en 2007

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach

artículo científico publicado en 2017

Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.

artículo científico publicado en 2015

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer

artículo científico publicado en 2005

Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01 ⬇️

artículo científico publicado el 18 de noviembre de 2011

Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

artículo científico publicado en 2017

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3

scientific article published on 03 June 2018

Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02 ⬇️

artículo científico publicado el 8 de abril de 2013

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic

scientific article published on 15 December 2017

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic

artículo científico publicado en 2020

Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive

artículo científico publicado en 2018

Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer

artículo científico publicado en 2017

Postoperative chemoradiotherapy in high risk locally advanced gastric cancer

artículo científico publicado en 2012

Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy

artículo científico publicado en 2007

Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas

artículo científico publicado en 2005

Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer

artículo científico publicado en 2018

Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial

scientific article published on 16 May 2020

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

artículo científico publicado en 2015

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

artículo científico publicado en 2005

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

artículo científico publicado en 2021

Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy ⬇️

artículo científico publicado el 7 de febrero de 2012

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

scientific article published in Novemer 2018

Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival

artículo científico

Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors

scientific article published on 02 April 2018

Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer

artículo científico publicado en 2019

Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients

scientific article published on 20 April 2020

Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy

artículo científico publicado en 2016

Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy

artículo científico publicado en 2016

Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.

artículo científico publicado en 2016

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

scientific article published on 22 January 2019

Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy

artículo científico publicado en 2010

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy

artículo científico publicado en 2010

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses

artículo científico publicado en 2016

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

artículo científico publicado en 2007

Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study ⬇️

artículo científico publicado el 25 de septiembre de 2010

Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer

artículo científico publicado en 2016

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy

artículo científico publicado en 2015

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

artículo científico publicado en 2015

Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients

scientific article published on 26 April 2019

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

artículo científico publicado en 2007

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma

artículo científico publicado en 2012

Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy

artículo científico publicado en 2010

Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma

artículo científico publicado en 2014

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.

artículo científico publicado en 2017

Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).

artículo científico publicado en 2015

Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.

artículo científico publicado en 2017

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Kore

artículo científico publicado en 2019

RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase ⬇️

artículo científico publicado el 19 de agosto de 2010

RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib ⬇️

artículo científico publicado el 19 de marzo de 2013

Radiation Response Prediction Model Based on Integrated Clinical and Genomic Data Analysis

artículo científico publicado en 2021

Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer

artículo científico publicado en 2015

Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer

artículo científico publicado en 2008

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)

scientific article published on 06 November 2019

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

artículo científico publicado en 2018

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based T

article

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

artículo científico publicado en 2015

Real-world Treatment Pattern and Outcomes of Hypercalcemia among Solid Tumor Patients ⬇️

artículo científico publicado en 2019

Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer

artículo científico publicado en 2005

Ribociclib and Endocrine Therapy in Breast Cancer. Reply

scientific article published on 01 October 2019

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

artículo científico publicado en 2018

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

artículo científico publicado en 2009

Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.

artículo científico publicado en 2009

Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience

artículo científico publicado en 2012

SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.

artículo científico

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor‒Positive/Human Epidermal Growth Factor Receptor 2‒Negative Advanced Breast Cancer.

artículo científico publicado en 2018

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial ⬇️

artículo científico publicado en 2016

Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA.

artículo científico publicado en 2014

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy ⬇️

artículo científico publicado el 15 de septiembre de 2013

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

artículo científico publicado en 2015

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

artículo científico publicado en 2009

Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer

artículo científico publicado en 2014

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

artículo científico publicado en 2015

Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy

artículo científico publicado en 2017

Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: is there a subpopulation that might have benefit from adjuvant chemotherapy?

artículo científico publicado en 2012

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

artículo científico publicado en 2016

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.

artículo científico publicado en 2016

Src as a Therapeutic Target in Biliary Tract Cancer

artículo científico publicado en 2016

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

artículo científico publicado en 2018

Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer ⬇️

artículo científico publicado el 20 de enero de 2012

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer

artículo científico publicado en 2016

Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation

artículo científico

Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12)

scientific article published on 22 October 2019

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy

artículo científico publicado en 2020

TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells

artículo científico publicado en 2014

TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials

artículo científico publicado en 2016

Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response

scientific article published on 26 September 2019

Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing

artículo científico publicado en 2013

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab

scientific article published on 19 October 2019

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy

artículo científico publicado en 2015

The Impact of Primary Tumor Resection on the Survival of Patients with Stage IV Breast Cancer

The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use ⬇️

artículo científico publicado el 5 de septiembre de 2012

The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

artículo científico publicado en 2015

The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines

artículo científico publicado en 2003

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

artículo científico publicado en 2008

The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer

artículo científico publicado en 2015

The effect of perceived social support on chemotherapy-related symptoms in patients with breast cancer: A prospective observational study

artículo científico publicado en 2019

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

artículo científico publicado en 2008

The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy

artículo científico publicado en 2013

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer

artículo científico publicado en 2013

The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines ⬇️

artículo científico publicado el 25 de diciembre de 2011

The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies

artículo científico publicado en 2017

The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen

artículo científico publicado el 1 de abril de 2012

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer

artículo científico publicado en 2009

The role of PET/CT in detection of gastric cancer recurrence

artículo científico publicado en 2009

The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progre

artículo científico publicado en 2016

The synergism between Belotecan and cisplatin in gastric cancer

scientific article published on 30 September 2006

The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma

artículo científico

Therapeutic implication of HER2 in advanced biliary tract cancer

artículo científico publicado en 2016

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

scientific article published on 11 December 2019

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

artículo científico publicado en 2020

Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

artículo científico publicado en 2008

Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

scientific article published on 04 July 2019

Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study

artículo científico publicado en 2017

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

artículo científico publicado en 2010

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation ⬇️

artículo científico publicado el 7 de octubre de 2012

Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer

artículo científico publicado en 2013

Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer

scientific article published on 01 July 2009

VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib ⬇️

artículo científico publicado el 1 de septiembre de 2011

Validation and comparison of CS-IHC4 scores with a nomogram to predict recurrence in hormone receptor-positive breast cancers

artículo científico publicado en 2014

Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy

scientific article published on 24 September 2009

Weight changes after adjuvant treatment in Korean women with early breast cancer

artículo científico publicado en 2008

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

artículo científico publicado en 2015

Why, when, and how to prevent hepatitis B virus reactivation in cancer patients undergoing chemotherapy

artículo científico publicado en 2011

Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression

artículo científico publicado en 2007

Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01) ⬇️

artículo científico publicado el 5 de octubre de 2010

[The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma]

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda